Inducible nitric oxide synthase mediates the change from retinal to vitreal neovascularization in ischemic retinopathy
AUTOR(ES)
Sennlaub, Florian
FONTE
American Society for Clinical Investigation
RESUMO
Intravitreal neovascular diseases are a major cause of blindness worldwide. It remains unclear why neovessels in many retinal diseases spread into the physiologically nonvascularized vitreous rather than into the ischemic retinal areas, where the angiogenic factors are released. Here we show that inducible nitric oxide synthase (iNOS) is expressed in the ischemic retina. Using iNOS knockout mice and the iNOS inhibitor 1400W, we demonstrate that iNOS expression inhibits angiogenesis locally in the avascular retina, mediated at least in part by a downregulation of VEGF receptor 2 (VEGFR2) in cells adjacent to iNOS-expressing cells. At the same time, pathological intravitreal neovascularization is considerably stronger in iNOS-expressing animals. These findings demonstrate that iNOS plays a crucial role in retinal neovascular disease and show that it offers an ideal target for the control of vitreal neovascularization through improvement of the vascularization of the hypoxic retina.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=208943Documentos Relacionados
- Expression of inducible nitric oxide synthase is increased in patients with heart failure due to ischemic disease
- Peroxynitrite generated by inducible nitric oxide synthase and NADPH oxidase mediates microglial toxicity to oligodendrocytes
- Inducible nitric oxide synthase in the cardiovascular system.
- Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides.
- Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages